Descriptor: "Verzenio (Medication)" / Publication Year Range: This year - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Verzenio (Medication)"' showing total 5 results

Start Over Descriptor "Verzenio (Medication)" Publication Year Range This year

Subjects: Boehringer Ingelheim GmbH -- Company sales and earnings, Eli Lilly and Co. -- Company sales and earnings, Jardiance (Medication), Trulicity (Medication), Verzenio (Medication), Mounjaro (Medication), Humalog (Medication), Zepbound (Medication), Diseases, Company sales and earnings, Company earnings/profit, Chronic diseases, Insulin lispro, Semaglutide
Abstract: INDIANAPOLIS: Eli Lilly and Company has issued the following news release: Eli Lilly and Company (NYSE: LLY) announced its financial results for the fourth quarter of 2024 and detailed 2025 [...]
Published: 2025

Subjects: Eli Lilly and Co. -- Company sales and earnings, Company earnings/profit, Business, Jardiance (Medication), Trulicity (Medication), Verzenio (Medication), Mounjaro (Medication), Zepbound (Medication)
Abstract: INDIANAPOLIS: Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024. 'Lilly had another strong growth quarter in Q3, with total revenue increasing [...]
Published: 2025

Subjects: Pfizer Inc., GSK PLC, Roche Holding (UK) Ltd., Seagen Inc., AstraZeneca PLC, Reuters Group PLC, Eli Lilly and Co., United States. Food and Drug Administration, Association of the British Pharmaceutical Industry, European Union, European Union. European Commission, Verzenio (Medication), Mounjaro (Medication), Yervoy (Medication), Paxlovid (Medication), Opdivo (Medication), Zepbound (Medication), Jemperli (Medication), Breyanzi (Medication), BCG, Stock offerings, B cells, BCG vaccines
Abstract: Reuters - AstraZeneca overhauls management of its China division, FT reports - 18/1/2025 AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's [...]
Published: 2025

Subjects: Pfizer Inc., GSK PLC, Roche Holding (UK) Ltd., Seagen Inc., Reuters Group PLC, AstraZeneca PLC, Eli Lilly and Co., United States. Food and Drug Administration, Association of the British Pharmaceutical Industry, European Union, Verzenio (Medication), Mounjaro (Medication), Yervoy (Medication), Paxlovid (Medication), Opdivo (Medication), Breyanzi (Medication), Blinatumomab, Evolocumab
Abstract: Bloomberg.com - Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight - 14/1/2025 Pfizer Inc.'s dispute with activist firm Starboard Value LP isn't 'an aggressive situation,' Chief Executive Officer [...]
Published: 2025

Subjects: Pfizer Inc., GSK PLC, Roche Holding (UK) Ltd., Seagen Inc., AstraZeneca PLC, Eli Lilly and Co., United States. Food and Drug Administration, Association of the British Pharmaceutical Industry, European Union, Nucala (Medication), Verzenio (Medication), Mounjaro (Medication), Yervoy (Medication), Paxlovid (Medication), Opdivo (Medication), Zepbound (Medication), Breyanzi (Medication), Care and treatment, Cancer treatment, Lung cancer -- Care and treatment, Blinatumomab, Nivolumab, Respiratory system agents, Anti-obesity agents, Evolocumab, Independent regulatory commissions, Drug approval, Weight loss -- Care and treatment, Semaglutide, Respiratory agents, Cancer -- Care and treatment, Weight reducing preparations
Abstract: PharmaTimes - Amgen's lung cancer treatment gets conditional approval - 6/1/2025 The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for IMDYLLTRA (tarlatamab), a [...]
Published: 2025

Books, media, physical & digital resources

Searchworks